Irish HSE to reconsider funding of MS drug Fampyra

Dalfampridine, or Ampyra, is a potassium channel blocker that is shown to improve visual function, motor skills and relieve fatigue in MS patients.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Irish HSE to reconsider funding of MS drug Fampyra

Post by MSUK » Wed Nov 19, 2014 5:41 am

The Irish Health Service Executive has said its drugs committee will meet to reconsider a decision not to fund a life-changing drug for multiple sclerosis patients.

Fampyra, or Fampridine, which is made by Biogen Idec, costs between €220 and €500 for a monthly dose.

Patients were receiving the drug for free until July of this year, but since then they have had to start paying for it themselves..... Read More - http://www.ms-uk.org/ampyra
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post